Spectroscopic and laser properties of three different Er3+−doped garnet systems are characterized by employing the Judd–Ofelt (JO) analysis. The three garnet hosts are Y3Al5O12 (YAG), Y3Sc2Ga3O12 (YSGG), and Gd3Ga5O12 (GGG). The JO model has been applied to the room temperature absorption intensities of Er3+ (4f11) transitions to establish the so-called JO intensity parameters: Ω2, Ω4, and Ω6 in the three garnet hosts. The intensity parameters are used to determine the radiative decay rates (emission probabilities of transitions) and branching ratios of the Er3+ transitions from the excited state J manifolds to the lower-lying J′ manifolds. The predicted decay rates and branching ratios of these Er3+ transitions in YAG, YSGG, and GGG hosts are compared. From the radiative decay rates, the radiative lifetimes of the Er3+ excited states are determined in the three garnets and are also compared. We also report the spectroscopic quality factors, Ω4/Ω6, obtained for the three garnets. The quantum efficiencies of the I413/2→I415/2 Er3+ transition in YAG, YSGG, and GGG are determined to be ∼79%, 82%, and 85%, respectively.
The surface tensions of various a : p-dihydroxy-aryloxypropanes in aqueous solution have been determined. Substitution of alkyl, alkoxyl and carboalkoxyl groups in the benzene nucleus of the a-phenyl ether of glycerol increases the capillary activity of the parent compound, the effect increasing with increase in the chain-length of the substituent. The increase in capillary activity is greatest with alkyl substituents and least with alkoxyl substituents. The effect of a substituent diminishes in the order : p -> m-> o-.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.